Chemoprevention of Prostate Cancer through Dietary Agents: Progress and Promise.

Chemoprevention of Prostate Cancer through Dietary Agents: Progress and Promise. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Chemoprevention of Prostate Cancer through Dietary Agents: Progress and Promise. Abstract Text:

Deeba N Syed,Naghma Khan,Farrukh Afaq,Hasan Mukhtar,Deeba N Syed,Naghma Khan,Farrukh Afaq,Hasan Mukhtar,

Prostate cancer (CaP) is second only to lung cancer as the cause of cancer-related deaths in American men and is responsible for over 29,000 deaths per year. One promising approach to reduce the incidence of CaP is through chemoprevention, which has been recognized as a plausible and cost-effective approach to reduce cancer morbidity and mortality by inhibiting precancerous events before the occurrence of clinical disease. Indeed, CaP is an ideal candidate disease for chemoprevention because it is typically diagnosed in the elderly population with a relatively slower rate of growth and progression, and therefore, even a modest delay in the development of cancer, achieved through pharmacologic or nutritional intervention, could result in substantial reduction in the incidence of clinically detectable disease. In this review, we have summarized the recent investigations and mechanistic studies on CaP chemoprevention using dietary agents, such as selenium, vitamins D and E, lycopene, phytoestrogens, flavonoids, and green tea polyphenols. Well-designed trials are required to delineate the potential clinical usefulness of these agents through issues, such as determining the optimal period and route of administration, systemic bioavailability, optimal dosing and toxicity of the agent, and single or combinatorial approach. It is hoped that, combining the knowledge based on agents with targets, effective approaches for CaP chemoprevention can be established. (Cancer Epidemiol Biomarkers Prev 2007;16(11):2193-204).

Chemoprevention of Prostate Cancer through Dietary Agents: Progress and Promise. Publishing Authors By Initials

DN Syed,N Khan,F Afaq,H Mukhtar,DN Syed,N Khan,F Afaq,H Mukhtar,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Chemoprevention of Prostate Cancer through Dietary Agents: Progress and Promise. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Cancer epidemiology, biomarkers & prevention : a p

VOLUME: 16

Page Numbers: 2193-203

Journal Abbreviation: Cancer Epidemiol. Biomarkers P

ISSN: 1055-9965

DAY: 16

MONTH: Nov

YEAR: 2007

Chemoprevention of Prostate Cancer through Dietary Agents: Progress and Promise. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9200608

Chemoprevention of Prostate Cancer through Dietary Agents: Progress and Promise. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Chemoprevention of Prostate Cancer through Dietary Agents: Progress and Promise. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Chemoprevention of Prostate Cancer through Dietary Agents: Progress and Promise.

AFFILIATION: Department of Dermatology, University of Wisconsin, Medical Sciences Center, Room B25, 1300 University Avenue, Madison, WI 53706. hmukhtar@wisc.edu.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Cancer Epidemiol Biomarkers Pr

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Chemoprevention of Prostate Cancer through Dietary Agents: Progress and Promise Related Publications

• A novel antioxidant 3-O-Caffeoyl-1-methylquinic acid enhances ultraviolet A-mediated apoptosis in immortalized HaCaT keratinocytes via Sp1-dependent transcriptional activation of p21(WAF1/Cip1).
• Apoptosis by dietary factors: the suicide solution for delaying cancer growth.
• Cancer chemoprevention through dietary antioxidants: progress and promise.
• Cannabinoids for cancer treatment: progress and promise.
• Chemoprevention of Prostate Cancer through Dietary Agents: Progress and Promise.
• Cholesterol-depleting statin drugs protect postmitotically differentiated human neurons against ethanol- and human immunodeficiency virus type 1-induced oxidative stress in vitro.
• Complete genome analysis of a highly pathogenic H5N1 influenza A virus isolated from a tiger in China.
• Constitutive overexpression of Nrf2-dependent heme oxygenase-1 in A549 cells contributes to resistance to apoptosis induced by epigallocatechin 3-gallate.
• Demographic and clinical features of diabetes mellitus in 1095 Yemeni patients.
• Dietary agents for chemoprevention of prostate cancer.
• Effects of highly active antiretroviral therapy on HIV-1-associated oral complications.
• Fisetin, a novel dietary flavonoid, causes apoptosis and cell cycle arrest in human prostate cancer LNCaP cells.
• Green tea and skin.
• Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis.
• Identification of Leishmania donovani as a cause of cutaneous leishmaniasis in Sudan.
• Inhibition of UVB-mediated oxidative stress and markers of photoaging in immortalized HaCaT keratinocytes by pomegranate polyphenol extract POMx.
• Inhibition of epidermal growth factor receptor signaling pathway by delphinidin, an anthocyanidin in pigmented fruits and vegetables.
• Letter: Neonatal hyperthyroidism and long-acting thyroid stimulator protector.
• Lupeol Inhibits Growth of Highly Aggressive Human Metastatic Melanoma Cells In vitro and In vivo by Inducing Apoptosis.
• MP 48 expression in red blood cells of renal transplant recipients.
• MP84 expression in the urine specimens of acute rejection renal transplant recipients.
• Neuroscience of HIV Infection - Eighth International Meeting. Basic Research and Clinical Frontiers.
• Oral consumption of pomegranate fruit extract inhibits growth and progression of primary lung tumors in mice.
• Pomegranate derived products for cancer chemoprevention.
• Pomegranate fruit extract inhibits prosurvival pathways in human A549 lung carcinoma cells and tumor growth in athymic nude mice.
• Prescribing for asthmatic children in primary care. Are we following guidelines?
• Prevention of prostate cancer through custom tailoring of chemopreventive regimen.
• Src kinase potentiates androgen receptor transactivation function and invasion of androgen-independent prostate cancer C4-2 cells.
• Tea beverage in chemoprevention and chemotherapy of prostate cancer.
• Unusual clinical presentation of a severely protruding premaxilla in patient with bilateral clefts.